The effectiveness of pharmacological agents for the treatment of uveitic macular oedema (UMO): a systematic review protocol

BACKGROUND: Macular oedema (MO) describes the accumulation of fluid in the central part of the retina, known as the ‘macula’ which provides central vision. MO is the leading cause of sight loss in patients with intraocular inflammation (uveitis). There is a lack of consensus over the treatment of uv...

Descripción completa

Detalles Bibliográficos
Autores principales: Tallouzi, Mohammad O., Moore, David J., Calvert, Melanie, Murray, Philip I., Bucknall, Nicholas, Denniston, Alastair K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752778/
https://www.ncbi.nlm.nih.gov/pubmed/26872918
http://dx.doi.org/10.1186/s13643-016-0203-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752778/
https://www.ncbi.nlm.nih.gov/pubmed/26872918
http://dx.doi.org/10.1186/s13643-016-0203-y

Ejemplares similares